Skip to main content
. 2023 Jan 16;10:1037157. doi: 10.3389/fpubh.2022.1037157

Figure 1.

Figure 1

Prototypes of MR-MAPs in development: Vaxxas (A) and Micron Biomedical (B). MR-MAP, measles and rubella microarray patches. All images are shared with the companies' permissions.